Journals / Turkish Journal of Gastroenterology / 2003 / Cilt: 14 - Sayı: 3

Karaciğerin berrak hücreli karsinomu: Olgu sunumu

Clear cell carcinoma of the liver: A case report

Pages
211–214
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The case was discussed in detail regarding histological presentation, with particular attention to histopathologic differential diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatocellular carcinoma represents the 8th most frequent malignancy worldwide.
📊
Key Findings & Data:A 52-year-old man presented with mild dyspeptic symptoms, right-sided upper abdominal pain, weakness, we-ight loss, abdominal mass and jaundice symptoms for nearly six weeks.
💡
Conclusion & Impact:The case was discussed in detail regarding histological presentation, with particular attention to histopathologic differential diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Biyopsi · Karaciğer neoplazmları · Erkek

Abstract

Hepatocellular carcinoma represents the 8th most frequent malignancy worldwide. The World Health Organization recogni-zes five histologic patterns and four cytologie variants of hepa-tocellular carcinoma. Clear cell carcinoma of the liver is a well-defined variant of hepatocellular carcinoma in which a large number of cells show clear cytoplasm that does not stain with hematoxylin and eosin. It can be confused with other clear-cell malignancies. A 52-year-old man presented with mild dyspeptic symptoms, right-sided upper abdominal pain, weakness, we-ight loss, abdominal mass and jaundice symptoms for nearly six weeks. After diagnostic procedures, an ultrasonography-guided liver biopsy was performed. In microscopic examination, malignant cells with vacuolated foamy to clear cytoplasm and central and eccentric nuclei, tumor composed of solid mass and cords, and clear cells were observed, and hepatocellular carcinoma, clear cell variant, is diagnosed. We report this rare case of primary clear cell carcinoma in the cirrhotic liver. The case was discussed in detail regarding histological presentation, with particular attention to histopathologic differential diagnosis.

Özet

Hepatosellüler karsinom (HSK) sıklık sırasına göre dünyada görülen sekizinci malignitedir. Dünya Sağlık Örgütü (WHO), HSKnın dört sitolojik ve beş histolojik tipini tanımlamaktadır. Karaciğerin berrak hücreli karsinomu hematoksilen eozinle boyanmayan çok sayıda berrak stoplazmalı hücrelerden oluşan HSK'nın iyi tanımlanmış bir tipidir. Diğer berrak hücreli kar-sinomlarla karışabilir. Elli iki yaşında, erkek hasta yaklaşık altı haftadır hafif dispepsi, sağ üst karın bölgesinde ağrı, zayıflama, kilo kaybı, karında kitle ve sarılık şikayetleri mevcuttu. Diğer tanısal tetkiklerden sonra, ultrasonografi eşliğinde karaciğerden biyopsi alındı. Mikroskobik incelemede, tümör berrak sitoplazmalı, köpüksü vakuollü santral ve ekzantrik yerleşimli nükleuslu hücrelerin solid kitle ve kordonlar oluşturan malign hücrelerden oluştuğu izlendi. Bu bulgularla hepatosellüler karsinomun berrak hücreli tipi tanısı kondu. Bu raporda, sirotik karaciğerde HSK'ın primer berrak hücreli tipini histopatolojik bulguları dikkatte alarak sunduk.

🔖

Cite This Article

KILINÇ, N., YALÇIN, K., DEĞERTEKİN, H., ÖZAYDIN, M. (2003). Karaciğerin berrak hücreli karsinomu: Olgu sunumu. Turkish Journal of Gastroenterology, Cilt: 14 - Sayı: 3, 211–214. https://ajindex.com/articles/411206

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Rosai J. Liver In: Ackerman's surgical pathology. 8th ed. St Louis: Mosby, 1996; 903-12
  2. Cong WM, Wu MC, Zhang XH, et al. Primary hepatocellular carcinoma in women of mainland China. A clinicopathologic analysis of 104 patients. Cancer 1993,71: 2941-45
  3. Schiff L. Diseases of the liver. 5th ed. Philadelphia: JB Lippincott, 1982; 1112-40
  4. Orsatti G, Arnold MM, Paronetto F. DNA image cytometric analysis of primary clear cell carcinoma of the liver. Arch Pathol Lab Med 1994; 118: 1226-29
  5. Zamboni G, Pea M, Martignoni G, et al. Clear cell "sugar" tumor of the pancreas. Am J Surg Pathol 1996; 20: 722-30
  6. Yang SH, Watanabe J, Nakashima O, et al. Clinicopathologic study on clear cell hepatocellular carcinoma. Pathol Inter 1996; 46: 503-9
  7. Lai CL, Wu PC, Lam KC, Todd D. Histologic prognostic indicators in hepatocellular carcinoma. Cancer 1979; 44: 1677-83
  8. Wu PC, Lai CL, Lam KC, et al. Clear cell carcinoma of the liver. Cancer 1983; 52: 504-7
  9. Ross JS, Kurian S. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia. Am J Gastroenterol 1985; 80: 188-94
  10. Buchanan TF, Huvos AG. Clear cell carcinoma of the liver. A clinicopathologic study of 13 patients. Am J Clin Pathol 1974; 61: 529-39
  11. Kishi K, Shikata T, Hirohashi S, et al. Hepatocellular carcinoma: a clinical and pathologic analysis of 57 hepatectomy cases. Cancer 1983; 51: 542-48
  12. Albores-Saavedra J, Hoang MP, Murakata LA, et al. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. Am J Surg Pathol 2001; 25: 956-60
  13. Murakata LA, Ishak KG, Nzeako UC. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 2000; 13: 874-81
  14. Adamek HE, Spiethoff A, Kaufmann V, et al. Primary clear cell carcinoma of noncirrhotic liver: immunohistochemical discrimination of hepatocellular and cholangiocellular origin. Dig Dis Sci 1998; 43: 33-38
  15. Fischer HP, Altmannsberger M, Weber K, et al. Keratin polypeptides in malignant epithelial liver tumors. Am J Patol 1987; 127: 530-37
  16. Sasaki K, Okuda S, Takahashi M, et al. Hepatic clear cell carcinoma associated with hypoglycemia and hypercholesterolemia. Cancer 1981; 47: 820-22
  17. Emile JF, Lemoine A, Azoulay D, et al. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology 2001; 38: 225-31
  18. Giarelli L, Melato M, Zancotani F, et al. Primary liver cancer in noncirr